Montefiore Medical Center, a major academic medical center in Bronx, New York (New York City) is currently recruiting men and women, ages 19-65 with physician-diagnosed, (Rome III criteria) irritable bowel syndrome with diarrhea (IBS-D) for a clinical trial to determine the possible safety, feasibility and effectiveness of fecal microbiota transplantation for IBS-D. Potential volunteers must have moderate to severe symptoms that have not been managed effectively with existing treatments, not be currently pregnant or nursing, and not have been treated with antibiotics within 3 months of study enrollment. There are several additional medical exclusion criteria that may also apply, as listed on ClinicalTrials.gov.
The study involves randomized assignment to oral capsules of fecal microbiota from extensively screened donor stool or placebo taken for three days. All volunteers will then cross over to the other group after 12 weeks and be followed for a total of 6 months.
If you are interested in volunteering to participate, please contact Olga C. Aroniadis, MD, at 718-920-4846, or email@example.com. The study’s ClinicalTrials.gov identifer is NCT02329547.
This information is summarized from a posting by IFFGD and from the study listing at ClinicalTrials.gov. Montefiore Medical Center is one of three sites conducting this trial, with two others in New York City and Hamden, Connecticut given in the Clinical Trials.gov listing. Please address any questions or concerns directly to the research center.
We welcome researchers affiliated with academic, medical or pharmaceutical entities, or reputable organizations representing IBS or related or commonly overlapping conditions, to contact us directly with additional studies or surveys they wish to be considered for posting. A contact form is available on the main IBS Impact website.
IBS Impact makes these announcements available for general information, and encourages its members and site visitors to make their own individual, informed choices about their potential participation. IBS Impact, as an entity, is not directly affiliated with any research sponsor or organization and receives no funding from any source for studies, surveys or links we feature on this blog, the main site or social media.